Abstract
To evaluate the anti-inflammatory action of macrolide antibiotics, we examined whether macrolide antibiotics could induce apoptosis of activated lymphocytes. The proportion of apoptotic cells was augmented by clarithromycin (CLR) and azithromycin (AZM) compared with control. There was no significant difference in Fas and Fas-ligand expression between the control and macrolide-treated groups. CLR and AZM inhibited the expression of Bcl-xL compared with that of control. Our results suggest that CLR and AZM enhance apoptosis of activated lymphocytes by down-regulation of Bcl-xL.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Bacterial Agents / pharmacology*
-
Antigen-Presenting Cells
-
Apoptosis / drug effects*
-
Azithromycin / pharmacology*
-
CD28 Antigens / immunology
-
CD3 Complex / immunology
-
Cells, Cultured
-
Clarithromycin / pharmacology*
-
Down-Regulation / drug effects
-
Down-Regulation / physiology
-
Fas Ligand Protein
-
Humans
-
In Vitro Techniques
-
Lymphocyte Activation / drug effects
-
Lymphocytes / drug effects*
-
Lymphocytes / immunology
-
Membrane Glycoproteins / biosynthesis
-
Proto-Oncogene Proteins c-bcl-2 / biosynthesis*
-
Stimulation, Chemical
-
bcl-2-Associated X Protein
-
bcl-X Protein
-
fas Receptor / biosynthesis
Substances
-
Anti-Bacterial Agents
-
BCL2L1 protein, human
-
CD28 Antigens
-
CD3 Complex
-
FASLG protein, human
-
Fas Ligand Protein
-
Membrane Glycoproteins
-
Proto-Oncogene Proteins c-bcl-2
-
bcl-2-Associated X Protein
-
bcl-X Protein
-
fas Receptor
-
Azithromycin
-
Clarithromycin